Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Exercise for MCI and Metabolic Syndrome
NCT00736996Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in Mild Cognitive Impairment (MCI), sponsored by University of Colorado Denver. Started Nov 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT00736996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736996.